Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy Men
Crossref DOI link: https://doi.org/10.1007/s40261-015-0285-7
Published Online: 2015-04-17
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Manitpisitkul, Prasarn
Mayorga, Arthur
Shalayda, Kevin
De Meulder, Marc
Romano, Gary
Jun, Chen
Moyer, John A.
Text and Data Mining valid from 2015-04-17